What is Relmada Therapeutics, Inc. Common Stock's Market Cap?

Relmada Therapeutics, Inc. Common Stock's Market Cap is $443.2M, based on as-reported figures from SEC (XBRL) filings.

What is Relmada Therapeutics, Inc. Common Stock's Enterprise Value?

Relmada Therapeutics, Inc. Common Stock's Enterprise Value is $209.3M, based on as-reported figures from SEC (XBRL) filings.

What is Relmada Therapeutics, Inc. Common Stock's Net Income (TTM)?

Relmada Therapeutics, Inc. Common Stock's Net Income (TTM) is -$58.9M, based on as-reported figures from SEC (XBRL) filings.

What is Relmada Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Relmada Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.55, based on as-reported figures from SEC (XBRL) filings.

What is Relmada Therapeutics, Inc. Common Stock's Net Debt?

Relmada Therapeutics, Inc. Common Stock's Net Debt is -$234.0M, based on as-reported figures from SEC (XBRL) filings.

Relmada Therapeutics, Inc. Common Stock (RLMD) Financial Statements

Relmada Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG003MKSL25

XNAS · usd

4.16▼ 0.09 (-2.24%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA—

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close4.25

Day's Range4.13 – 4.43

52-Week Range1.44 – 8.00

Volume1.7M

Avg Volume1.1M

Share Statistics

Shares Outstanding

Employees17

ExchangeXNAS

Listed2014-03-03

Share count as of August 4, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Relmada Therapeutics, Inc. Common Stock (RLMD)

What is Relmada Therapeutics, Inc. Common Stock's Market Cap?: Relmada Therapeutics, Inc. Common Stock's Market Cap is $443.2M, based on as-reported figures from SEC (XBRL) filings.
What is Relmada Therapeutics, Inc. Common Stock's Enterprise Value?: Relmada Therapeutics, Inc. Common Stock's Enterprise Value is $209.3M, based on as-reported figures from SEC (XBRL) filings.
What is Relmada Therapeutics, Inc. Common Stock's Net Income (TTM)?: Relmada Therapeutics, Inc. Common Stock's Net Income (TTM) is -$58.9M, based on as-reported figures from SEC (XBRL) filings.
What is Relmada Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Relmada Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.55, based on as-reported figures from SEC (XBRL) filings.
What is Relmada Therapeutics, Inc. Common Stock's Net Debt?: Relmada Therapeutics, Inc. Common Stock's Net Debt is -$234.0M, based on as-reported figures from SEC (XBRL) filings.